AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Hfnc oxygen12/30/2023 ![]() ![]() The above information is an educational aid only. You always have the right to refuse treatment. Discuss treatment options with your healthcare providers to decide what care you want to receive. Learn about your health condition and how it may be treated. You have the right to help plan your care. This includes checking your blood oxygen level regularly with a pulse oximeter. You will also get instructions for using oxygen safely. You will get information on how to clean the parts and how much extra oxygen to keep as a backup. Healthcare providers will show you how to set up and use the device at home. What do I need to know about HFNC use at home? HFNC can keep oxygen at the right level while intubation tubes are being placed and removed. For example, breathing problems can develop during intubation. Prevents breathing problems before and after a procedure or surgery.HFNC does not use a mask, so it may be more comfortable than CPAP. A CPAP mask may be difficult to wear during sleep. OSA is usually treated with a continuous positive air pressure (CPAP) machine. HFNC can be used to manage obstructive sleep apnea (OSA). This makes it easier to cough up or remove. It can also help thin mucus that may form in the lungs. Conditions such as COPD, pneumonia, and respiratory failure can cause low blood oxygen levels. Manages lung conditions in older children and adults.HFNC can help the baby breathe more regularly. AOP causes the baby to stop breathing for 15 to 20 seconds or to pause for several seconds. This can cause a condition called apnea of prematurity (AOP). Premature babies are born earlier than 37 weeks, before certain parts of the body have fully formed. It also helps clear carbon dioxide from the airway. The lungs do not have to work as hard to get air in and out. The high flow rate makes breathing easier. ![]() The oxygen is delivered through small prongs that sit in the nostrils. HFNC is used to give oxygen at a high rate. I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Medically reviewed by. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as. This study was reviewed and approved by the Medical Ethical Committee of participating institutes (PJ2020-005), and the informed consent was waived by the Medical Ethical CommitteeĪll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. The details of the IRB/oversight body that provided approval or exemption for the research described are given below: I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. The authors' work was supported by the grants from National Natural Science Foundation of China (NSFC 813000674, 81670770, 81970247). The authors have declared no competing interest. This suggests HFNC could be considered early in this disease process. It is concluded that the Prognosis was better in severely ill elderly patients with COVID-19 receiving early compared to late HFNC. Twenty-four patients died during hospitalization, of whom 22 deaths (30.6%) were in the late HFNC group and 2(5.3%) in the early HFNC group. Compared with the late HFNC group, patients in the early HFNC group had a lower likelihood of developing severe ARDS, longer time from illness onset to severe ARDS and shorter duration of viral shedding after illness onset, as well as shorter lengths of ICU and hospital stay. Thirty-eight patients received HFNC when 200 mmHg < PO 2/FiO 2 ≤ 300 mmHg (early HFNC group), and 72 patients received HFNC treatment when 100 mmHg < PaO 2/FiO 2 ≤ 200 mmHg (late HFNC group). Of the 110 patients, the median age was 71 years (IQR, 68-78) and 59.1% was male. We retrospectively analyzed the clinical data of 110 elderly patients (≥65 years) who received HFNC from Renmin Hospital of Wuhan University, People’s Hospital of Xiantao City and Chinese Medicine Hospital of Shishou City in Hubei Province, China, and from Affiliated Hospital of Guangdong Medical University, People’s Hospital of Yangjiang City, People’s Hospital of Maoming City in Guangdong Province, China. High-flow nasal cannula therapy (HFNC) is a major oxygen supporting therapy for severely ill patients, but information regarding the timing of HFNC application is scarce, especially in elderly patients. Coronavirus disease-2019 (COVID-19) has rapidly spread worldwide. ![]()
0 Comments
Read More
Leave a Reply. |